ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

1,05
0,01
(0,96%)
Geschlossen 16 Februar 10:00PM
1,05
0,00
(0,00%)
Nach Börsenschluss: 11:59PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
1,05
Gebot
1,02
Fragen
1,15
Volumen
74.699
1,02 Tagesbereich 1,07
0,8101 52-Wochen-Bereich 4,59
Marktkapitalisierung
Handelsende
1,04
Handelsbeginn
1,0304
Letzte Trade
3
@
1.06
Letzter Handelszeitpunkt
Finanzvolumen
US$ 78.739
VWAP
1,0541
Durchschnittliches Volumen (3 Mio.)
202.906
Ausgegebene Aktien
20.880.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,75
Gewinn pro Aktie (EPS)
-1,39
Erlöse
-
Nettogewinn
-29,07M

Über Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Ness Ziona, Center, Isr
Gegründet
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was US$1,04. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0,8101 to US$ 4,59.

Enlivex Therapeutics currently has 20.880.000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$21,72 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.75.

ENLV Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.043.96039603961.011.141392551.07023248CS
4-0.11-9.482758620691.161.2051489811.11515992CS
120.18050120.75919581280.8694991.34650.832029061.23194208CS
26-0.19-15.32258064521.241.750.81011589191.30272932CS
52-2.06-66.23794212223.114.590.81011388721.6602423CS
156-3.95-7958.640.8101760762.54691606CS
260-7.15-87.19512195128.229.40.81011774188.85381999CS

ENLV - Frequently Asked Questions (FAQ)

What is the current Enlivex Therapeutics share price?
The current share price of Enlivex Therapeutics is US$ 1,05
How many Enlivex Therapeutics shares are in issue?
Enlivex Therapeutics has 20.880.000 shares in issue
What is the market cap of Enlivex Therapeutics?
The market capitalisation of Enlivex Therapeutics is USD 21,72M
What is the 1 year trading range for Enlivex Therapeutics share price?
Enlivex Therapeutics has traded in the range of US$ 0,8101 to US$ 4,59 during the past year
What is the PE ratio of Enlivex Therapeutics?
The price to earnings ratio of Enlivex Therapeutics is -0,75
What is the reporting currency for Enlivex Therapeutics?
Enlivex Therapeutics reports financial results in USD
What is the latest annual profit for Enlivex Therapeutics?
The latest annual profit of Enlivex Therapeutics is USD -29,07M
What is the registered address of Enlivex Therapeutics?
The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
What is the Enlivex Therapeutics website address?
The website address for Enlivex Therapeutics is www.enlivex.com
Which industry sector does Enlivex Therapeutics operate in?
Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
104,48M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
WRDWeRide Inc
US$ 31,4877
(83,39%)
21,07M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,68M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
136,66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock